Study guide

4.3 Bone Pathology, Jaw Disorders & Salivary Gland Diseases

Licentiate in Dental Surgery LDS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Clinically Applied Human Disease & General Medicine

1.1 Cardiovascular, Respiratory & Endocrine Disorders in Dental Practice 1.2 Haematology, Hepatic & Renal Disease & Bleeding Disorders 1.3 Medical Emergencies in the Dental Chair & Management

2 Chapter 2: Special Medical Considerations & Compromised Patients

2.1 Dental Management of Medically Compromised Patients 2.2 Immunocompromised, Transplants & Oncology Patients 2.3 Pregnancy, Ageing & Special Needs Patients in Dentistry

3 Chapter 3: Oral Biology, Dental Anatomy & Embryology

3.1 Face, Palate & Tooth Development & Embryology 3.2 Tooth Morphology, FDI Numbering & Eruption Sequences 3.3 Structure & Function of Dental Hard Tissues 3.4 Pulp-Dentine Complex, Periodontium & Salivary Gland Physiology

4 Chapter 4: Oral & Maxillofacial Pathology

4.1 Caries & Periodontal Histopathology & Pathogenesis 4.2 Odontogenic Cysts, Tumours & Developmental Anomalies 4.3 Bone Pathology, Jaw Disorders & Salivary Gland Diseases

5 Chapter 5: Oral Medicine & Mucosal Diseases

5.1 Potentially Malignant Disorders & Oral Squamous Cell Carcinoma 5.2 Vesiculobullous, Ulcerative & Autoimmune Mucosal Conditions 5.3 Oral Infections & Orofacial Pain Management

6 Chapter 6: Oral Microbiology & Infection Control

6.1 Oral Microflora, Dental Plaque Biofilm & Microbial Ecology 6.2 Cariogenic & Periodontal Pathogens & Systemic Links 6.3 Cross-Infection Control, Sterilisation, Decontamination & HTM 01-05

7 Chapter 7: Pharmacology & Therapeutics

7.1 Local Anaesthetics, Dosing, Vasoconstrictors & Toxicity 7.2 Analgesics, NSAIDs, Opioids & Conscious Sedation Pharmacology 7.3 Antimicrobial Prescribing, BNF/DPF Guidance & Stewardship 7.4 Drugs Affecting Haemostasis, Bone (MRONJ) & Drug Interactions

8 Chapter 8: Dental Materials Science

8.1 Amalgam, Composite Resins, Bonding Agents & Adhesion 8.2 Glass-Ionomer Cements, Resin-Modified GICs & Luting Cements 8.3 Impression Materials, Gypsum Products & Dental Waxes 8.4 Dental Ceramics, Restorative Alloys & Material Biocompatibility

9 Chapter 9: Principles of Clinical Dentistry

9.1 Operative Dentistry, Endodontics & Periodontology Principles 9.2 Fixed & Removable Prosthodontics & Occlusion 9.3 Paediatric Dentistry, Orthodontics & Oral Surgery Essentials 9.4 Dental Radiography, Image Interpretation & Radiation Protection (IRR17/IRMER17)

10 Chapter 10: Law, Ethics, Governance & Health & Safety

10.1 GDC Standards for the Dental Team & Professionalism 10.2 Valid Consent, Capacity (MCA), Confidentiality & Safeguarding 10.3 Health & Safety, Clinical Governance, Audit & Risk Management

4.3 Bone Pathology, Jaw Disorders & Salivary Gland Diseases

Key Takeaways Explain This Topic AI

Fibrous dysplasia is caused by somatic activating GNAS gene mutations, replacing normal bone with cellular fibrous stroma and non-functional, irregular woven bone trabeculae lacking osteoblastic rimming ('Chinese character' shape) that blend imperceptibly into surrounding bone with a ground-glass radiographic appearance.

Paget's disease of bone (osteitis deformans) involves dysregulated bone remodeling leading to a mosaic or 'jigsaw puzzle' pattern of reversal lines, cotton-wool radiographic sclerosis, hypercementosis, and markedly elevated serum alkaline phosphatase (ALP).

Medication-Related Osteonecrosis of the Jaw (MRONJ) is diagnosed when exposed necrotic jawbone or bone probed through a fistula persists for >8 weeks in patients treated with anti-resorptive (bisphosphonates, denosumab) or anti-angiogenic agents without prior radiation therapy to the head and neck.

Pleomorphic adenoma is the most common benign salivary gland neoplasm, composed of epithelial and myoepithelial elements within a variable chondromyxoid or hyaline stroma, enclosed in an incomplete fibrous pseudocapsule requiring wide margin excision to prevent recurrence.

Adenoid cystic carcinoma is a high-grade malignant salivary tumour characterized by prominent perineural invasion, early pain or facial nerve palsy, a cribriform ('Swiss cheese') histological arrangement of pseudocysts containing basement membrane material, and a high propensity for late distant lung metastases.

Last updated: July 2026

Bone Pathology, Jaw Disorders & Salivary Gland Diseases

Pathologies affecting the maxillofacial skeleton and salivary glands comprise a diverse group of neoplastic, metabolic, reactive, and autoimmune disorders. Mastery of clinical diagnostic criteria, histopathological features, and molecular etiologies is required for the LDS Part 1 examination.

Benign Fibro-Osseous Lesions of the Jaws

Fibro-osseous lesions share a common histological footprint: normal architecture is replaced by cellular fibrous tissue containing varying amounts of mineralised material (woven bone, lamellar bone, or cementum-like spherules).

Entity Genetic / Etiological Drivers Demographics & Radiography Key Histopathology

Fibrous Dysplasia Somatic activating mutation in GNAS gene (α subunit of Gs protein). Children/young adults; painless expansion of maxilla; poorly demarcated ground-glass radiopacification. Cellular fibrous stroma with irregular, non-functional woven bone trabeculae lacking osteoblastic rimming ("Chinese character" pattern).

Cemento-Osseous Dysplasia (COD) Reactive defect of periodontal ligament origin. Middle-aged Afro-Caribbean females; vital teeth; periapical, focal, or florid patterns. Mixed fibrous tissue, woven bone, and acellular cementum-like masses. Risk of secondary osteomyelitis.

Ossifying Fibroma True benign neoplasm. Females in 3rd–4th decade; posterior mandible; well-circumscribed, encapsulated radiolucency with radiopaque foci. Fibrous capsule enclosing cellular stroma with calcified ossicles/cementum-like drops demonstrating prominent osteoblastic rimming . Fibrous Dysplasia vs. Ossifying Fibroma Differentiation:

  • Fibrous Dysplasia ──► GNAS Mutation + Poorly Demarcated "Ground-Glass" + NO Osteoblastic Rimming
  • Ossifying Fibroma ──► True Neoplasm + Encapsulated / Well-Demarcated + PROMINENT Osteoblastic Rimming
  • Metabolic & Osteonecrotic Jaw Pathologies
  • Paget's Disease of Bone (Osteitis Deformans)

Pathophysiology : Uncoordinated, dysregulated bone remodeling characterized by intense osteoclastic resorption followed by chaotic, disorganized osteoblastic deposition.

Clinical Features : Occurs in patients >50 years; progressive enlargement of the skull and maxilla ("leontiasis ossea"), spacing of teeth, poorly fitting dentures.

Biochemical & Radiographic Findings : Serum alkaline phosphatase (ALP) is markedly elevated, while serum calcium and phosphate levels remain normal. Radiographs show cotton-wool radiopacities and extensive hypercementosis of tooth roots.

Histopathology : Bone exhibits a pathognomonic mosaic or jigsaw puzzle pattern of basophilic reversal lines caused by repeated phases of destruction and repair. Paget's Disease Histopathology & Biochemistry:

  • Histology: Mosaic / "Jigsaw Puzzle" Pattern of Reversal Lines
  • Biochemistry: Markedly Elevated Serum Alkaline Phosphatase (ALP)
  • Radiography: "Cotton-Wool" Sclerosis + Generalized Hypercementosis
  • Medication-Related Osteonecrosis of the Jaw (MRONJ)
  • Official Diagnostic Criteria

Diagnosis of MRONJ requires ALL three of the following parameters:

Current or previous treatment with antiresorptive agents (bisphosphonates like zoledronic acid/alendronate, RANKL inhibitors like denosumab ) or antiangiogenic targeted therapies .

Exposed necrotic bone in the maxillofacial region or bone that can be probed through an intraoral or extraoral fistula persisting for more than 8 weeks .

No history of radiation therapy to the jaws or obvious metastatic disease of the jaws.

Staging & Pathogenesis

Stage 0 : Non-exposed bone variant; unexplainable pain, dull bone ache, loosening of teeth, radiographic bone loss without bone exposure.

Stage 1 : Exposed necrotic bone or fistula probing to bone; asymptomatic with no evidence of infection/soft tissue inflammation.

Stage 2 : Exposed necrotic bone or fistula; symptomatic with infection, erythema, purulent discharge, and pain.

Stage 3 : Exposed necrotic bone extending beyond alveolar bone (e.g., inferior border of mandible, maxillary sinus, pathologic fracture, extraoral fistula).

Pathogenesis : Severe osteoclast inhibition prevents physiological bone microdamage repair, combined with local microvascular anti-angiogenic suppression, mucosal trauma (e.g., tooth extraction), and secondary bacterial colonisation ( Actinomyces ).

Osteoradionecrosis (ORN)

Definite diagnosis requires necrotic exposed bone in an area previously irradiated for head and neck malignancy that fails to heal over 3 months, in the absence of tumour recurrence.

Marx Triad Pathogenesis : Radiation induces Hypoxia , Hypovascularity , and Hypocellularity , leading to chronic tissue breakdown and unhealing aseptic necrosis. High-risk threshold: radiation doses exceeding 60 Gy .

  • Giant Cell & Hereditary Jaw Lesions
  • Central Giant Cell Granuloma (CGCG)

Histopathology : Non-neoplastic proliferation of multinucleated osteoclast-like giant cells unevenly distributed within a vascular stroma of spindle-shaped mesenchymal cells. Demonstrates extravasated red blood cells, hemosiderin deposition , and reactive woven bone trabeculae.

Clinical Note : Must rule out Hyperparathyroidism (Brown tumor of hyperparathyroidism exhibits identical histology; evaluate serum calcium, phosphate, and parathyroid hormone [PTH] levels).

Cherubism

Genetics : Autosomal dominant disorder with high penetrance caused by mutations in the SH3BP2 gene (chromosome 4p16).

Clinical Presentation : Appears in early childhood (2–5 years) with painless, bilateral swelling of the mandibular angles and maxilla, causing upward gaze of eyes ("cherubic" appearance).

Histopathology : Multinucleated giant cells embedded in a fibrous stroma containing pathognomonic perivascular eosinophilic collagen cuffing around capillaries. Lesions typically regress spontaneously after puberty.

  • Non-Neoplastic Salivary Gland Diseases
  • Sialolithiasis

Salivary calculi (stones) occur predominantly in the submandibular gland system (80–85%) within Wharton's duct .

Predisposing Factors : Wharton's duct has a long, tortuous, upward-sloping anatomical course; submandibular saliva is higher in calcium and phosphate, more alkaline, and richer in mucin proteins compared to parotid saliva.

Clinical Symptoms : Mealtime syndrome — acute, painful swelling of the submandibular gland triggered by eating due to ductal obstruction.

Sjögren's Syndrome

Systemic autoimmune exocrinopathy characterized by lymphocytic destruction of salivary and lacrimal glands.

Primary vs. Secondary : Primary Sjögren's (dry eyes [keratoconjunctivitis sicca] + dry mouth [xerostomia]); Secondary Sjögren's (sicca complex combined with a connective tissue disease like Rheumatoid Arthritis or Systemic Lupus Erythematosus).

Serology : Positive autoantibodies anti-Ro (SS-A) and anti-La (SS-B) , positive Rheumatoid Factor (RF), and ANA.

Minor Salivary Gland Biopsy Criteria : Labial salivary gland biopsy demonstrating focal lymphocytic sialadenitis with a Focus Score ≥1 per 4 mm² of tissue (a focus is defined as an aggregate of ≥50 lymphocytes, predominantly CD4+ T-cells, adjacent to acini).

Malignancy Risk : Patients with Sjögren's syndrome carry a 44-fold increased risk of developing non-Hodgkin B-cell lymphoma, specifically MALT Lymphoma (Mucosa-Associated Lymphoid Tissue lymphoma) in the parotid gland.

Salivary Gland Neoplasms

Salivary gland tumours follow the general rule: the smaller the salivary gland, the higher the probability of malignancy (Parotid: 20% malignant; Submandibular: 50% malignant; Sublingual/Minor glands: 80% malignant). Salivary Tumour Malignancy Rule:

  • Parotid Gland ──────► 80% Benign / 20% Malignant
  • Submandibular Gland ─► 50% Benign / 50% Malignant
  • Minor / Sublingual ──► 20% Benign / 80% Malignant
  • Benign Salivary Neoplasms
  • Pleomorphic Adenoma (Benign Mixed Tumour)

Frequency : The most common salivary gland tumour overall (~70% of parotid tumours).

Histopathology : Characterized by remarkable architectural diversity. Consists of a mixture of epithelial and myoepithelial cells embedded in a variable chondromyxoid , mucinous, or hyaline stroma.

Surgical Consideration : Possesses an incomplete fibrous pseudocapsule with microscopic tongue-like projections (pseudopods). Simple enucleation results in high recurrence rates; managed by partial parotidectomy. Risk of malignant transformation into Carcinoma ex Pleomorphic Adenoma (~5% of long-standing cases).

Warthin's Tumour (Papillary Cystadenoma Lymphomatosum)

Etiology & Location : Monomorphic benign tumour almost exclusively occurring in the tail of the parotid gland. Strongly linked to cigarette smoking (8-fold risk increase).

Histopathology : Cystic spaces lined by a double layer of oncocytic epithelial cells (tall granular eosinophilic luminal cells and small basal cells) exhibiting papillary projections, surrounded by a dense lymphoid stroma with germinal centres .

Malignant Salivary Neoplasms

Neoplasm Preferred Site Histopathological Features Clinical Behavior & Course

Mucoepidermoid Carcinoma Parotid gland; palate (minor glands). Mixture of three cell types: mucin-secreting cells , epidermoid (squamous) cells , and intermediate cells. Most common malignant salivary tumour in adults and children. Low-grade (cystic, mucin-rich) vs High-grade (solid, epidermoid-dominant).

Adenoid Cystic Carcinoma Submandibular and minor salivary glands (palate). Basophil-like cells forming a cribriform "Swiss cheese" pattern of pseudocysts filled with basement membrane material; tubular and solid subtypes. Notorious for perineural invasion (pain, facial nerve palsy) and late, relentless distant metastases to lungs/bone decades later.

Acinic Cell Carcinoma Almost exclusively Parotid gland. Serous acinar differentiation with abundant basophilic granular cytoplasm resembling normal parotid acini. Low-grade malignant neoplasm; indolent behavior but potential for recurrence.